Clinical trials
Recruiting Myelodysplastic Syndromes trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 5 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Beijing 302 Hospital | 2 |
| First Affiliated Hospital of Zhejiang University | 2 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2 |
| Ascentage Pharma Group Inc. | 1 |
| BeOne Medicines | 1 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Celgene | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 30 |
| Leukemia, Myeloid, Acute | 18 |
| Anemia, Aplastic | 3 |
| Lymphoma | 3 |
| Multiple Myeloma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia, Hemolytic, Autoimmune | 2 |
| Hematologic Neoplasms | 2 |
| Hemophilia A | 2 |
| Hemostatic Disorders | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.